According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,71ย โฌ. In 2017 the company made an earnings per share (EPS) of -17,61ย โฌ an increase over its 2016 EPS that were of -20,41ย โฌ.